JanOne to acquire Delaware-based blockchain innovator ALT 5 Sigma
JanOne Inc. (Nasdaq: JAN), a key player in the technology sector, has reached a definitive agreement to acquire ALT 5 Sigma Inc., a Delaware-based pioneer ... Read More
CoreRx to formulate and manufacture JanOne’s peripheral artery disease candidate
JanOne has signed a manufacturing agreement with cGMP contract manufacturer CoreRx for the clinical formulation and manufacturing of its lead drug candidate TV1001SR, a potential ... Read More